Cargando…
Is CDK9 a promising target for both primary and metastatic osteosarcoma?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413331/ https://www.ncbi.nlm.nih.gov/pubmed/30651218 http://dx.doi.org/10.1016/j.ebiom.2019.01.016 |
_version_ | 1783402795310776320 |
---|---|
author | Qin, Jiang-Jiang |
author_facet | Qin, Jiang-Jiang |
author_sort | Qin, Jiang-Jiang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6413331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64133312019-03-21 Is CDK9 a promising target for both primary and metastatic osteosarcoma? Qin, Jiang-Jiang EBioMedicine Commentary Elsevier 2019-01-14 /pmc/articles/PMC6413331/ /pubmed/30651218 http://dx.doi.org/10.1016/j.ebiom.2019.01.016 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Qin, Jiang-Jiang Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title | Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title_full | Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title_fullStr | Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title_full_unstemmed | Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title_short | Is CDK9 a promising target for both primary and metastatic osteosarcoma? |
title_sort | is cdk9 a promising target for both primary and metastatic osteosarcoma? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413331/ https://www.ncbi.nlm.nih.gov/pubmed/30651218 http://dx.doi.org/10.1016/j.ebiom.2019.01.016 |
work_keys_str_mv | AT qinjiangjiang iscdk9apromisingtargetforbothprimaryandmetastaticosteosarcoma |